AI Agents & Applications · advanced · concept 256 of 311 · Updated Nov 4, 2026

🤖AI-Driven Drug Discovery

Using AI to identify, design, and optimize drug candidates, dramatically accelerating the traditional 10-15 year drug development cycle. AlphaFold made protein structure prediction reliable enough to use as a tool. Insilico Medicine's rentosertib is the first candidate whose biological target and molecule were both found with generative AI, and it cleared a Phase IIa readout in 2025. It is still investigational, not approved, which is the honest state of the field.